Race and Genomics
Authors:
- Richard S. CooperRCRichard S. Cooper
- Jay S. KaufmanJKJay S. Kaufman
- Ryk WardRWRyk Ward
- 20 March 2003
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 348 (12) , 1166-1170
Abstract
These two articles present contrasting views of the usefulness of the concept of race in biomedical research and clinical practice.Keywords
This publication has 27 references indexed in Scilit:
- Genetic Structure of Human PopulationsScience, 2002
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Variant of SCN5A Sodium Channel Implicated in Risk of Cardiac ArrhythmiaScience, 2002
- Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patientsJACC, 2002
- African-American Heart Failure Trial (A-HeFT): Rationale, design, and methodologyJournal of Cardiac Failure, 2002
- Population genetic structure of variable drug responseNature Genetics, 2001
- Haplotype Variation and Linkage Disequilibrium in 313 Human GenesScience, 2001
- Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular DysfunctionNew England Journal of Medicine, 2001
- Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trialsJournal of Cardiac Failure, 1999
- The Bell Curve: On Race, Social Class, and Epidemiologic ResearchAmerican Journal of Epidemiology, 1996